Polar Capital Holdings Plc Lowers Position in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Polar Capital Holdings Plc lowered its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 9.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 349,761 shares of the company's stock after selling 34,818 shares during the period. Polar Capital Holdings Plc owned 0.38% of Acadia Healthcare worth $13,868,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently modified their holdings of ACHC. JPMorgan Chase & Co. raised its position in shares of Acadia Healthcare by 17.0% during the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company's stock valued at $198,258,000 after buying an additional 454,044 shares during the last quarter. Nisa Investment Advisors LLC raised its position in shares of Acadia Healthcare by 40.7% during the fourth quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company's stock valued at $41,000 after buying an additional 301 shares during the last quarter. SG Americas Securities LLC increased its position in Acadia Healthcare by 713.3% in the fourth quarter. SG Americas Securities LLC now owns 110,866 shares of the company's stock worth $4,396,000 after purchasing an additional 97,235 shares during the last quarter. Inspire Investing LLC increased its position in Acadia Healthcare by 54.2% in the fourth quarter. Inspire Investing LLC now owns 10,249 shares of the company's stock worth $406,000 after purchasing an additional 3,602 shares during the last quarter. Finally, Fifth Third Bancorp increased its position in Acadia Healthcare by 56.0% in the fourth quarter. Fifth Third Bancorp now owns 1,264 shares of the company's stock worth $50,000 after purchasing an additional 454 shares during the last quarter.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on ACHC shares. KeyCorp reduced their price target on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research report on Wednesday, May 14th. Guggenheim started coverage on shares of Acadia Healthcare in a research report on Wednesday, April 9th. They issued a "buy" rating and a $36.00 price target on the stock. Barclays reduced their price target on shares of Acadia Healthcare from $35.00 to $28.00 and set an "equal weight" rating on the stock in a research report on Wednesday, May 14th. Bank of America dropped their price objective on shares of Acadia Healthcare from $50.00 to $44.50 and set a "buy" rating for the company in a research note on Friday, February 28th. Finally, Royal Bank of Canada dropped their price objective on shares of Acadia Healthcare from $64.00 to $43.00 and set an "outperform" rating for the company in a research note on Monday, March 3rd. One research analyst has rated the stock with a sell rating, three have issued a hold rating and six have given a buy rating to the stock. According to data from MarketBeat, Acadia Healthcare has an average rating of "Moderate Buy" and a consensus target price of $47.94.

Acadia Healthcare Trading Down 3.7%

Shares of ACHC traded down $0.93 during trading hours on Wednesday, reaching $24.27. 364,781 shares of the company traded hands, compared to its average volume of 1,706,059. The firm has a market cap of $2.24 billion, a price-to-earnings ratio of 7.97, a PEG ratio of 1.46 and a beta of 1.01. Acadia Healthcare Company, Inc. has a 12-month low of $20.36 and a 12-month high of $82.41. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The stock's fifty day moving average price is $26.06 and its 200 day moving average price is $35.30.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its earnings results on Monday, May 12th. The company reported $0.40 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.35 by $0.05. The firm had revenue of $770.51 million during the quarter, compared to analyst estimates of $769.90 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The business's revenue was up .3% on a year-over-year basis. During the same period in the previous year, the firm earned $0.84 earnings per share. Sell-side analysts forecast that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.